Related Experiment Video

Updated: Jul 12, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

Young onset Parkinson's disease. Practical management of medical issues

Susan M Calne1, Ajit Kumar

  • 1Pacific Parkinson's Research Centre, University of Britsh Columbia, Vancouver, BC, Canada V6T 2B5. scalne@interchange.ubc.ca <scalne@interchange.ubc.ca>

Parkinsonism & Related Disorders
|September 7, 2007
PubMed

Insights

Young Onset Parkinson's disease (YOPD) presents unique challenges for patients diagnosed between 21 and 40. This review offers practical management strategies for lifelong YOPD care.

Area of Science:

  • Neurology
  • Movement Disorders
  • Geriatrics

Background:

  • Young Onset Parkinson's disease (YOPD) affects individuals aged 21–40.
  • YOPD patients face decades of illness, necessitating distinct management approaches.
  • Standard Parkinson's disease care often overlooks YOPD-specific issues.

Purpose of the Study:

  • To review current literature on managing YOPD.
  • To provide practical intervention suggestions for YOPD patients.
  • To address areas of particular difficulty for YOPD individuals.

Main Methods:

  • Literature review of YOPD management strategies.
  • Synthesis of current research findings.
  • Identification of practical self-management techniques.

Main Results:

  • YOPD requires tailored approaches in medication, rehabilitation, and lifestyle.
  • Specific considerations for sexuality, pregnancy, and menopause are crucial.
  • Proactive self-management empowers individuals with YOPD.

Conclusions:

  • Comprehensive, YOPD-specific care is essential for long-term well-being.
  • Interventions should address the unique lifelong trajectory of YOPD.
  • Empowering patients with self-management tools improves quality of life.

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...